In 2024, Ryman Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Ryman Healthcare has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 4,318a | N/A | N/A | |
Total Scope 2 | ||||
Market-Based | 8,234a | N/A | N/A | |
Location-Based | 9,623a | N/A | N/A | |
Total Scope 3 | 4,123a | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 11.0951a | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Ryman Healthcare amounted to 13,941 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2021, the total operational greenhouse gas (GHG) emissions of Ryman Healthcare increased by 13.18%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Ryman Healthcare were 4,318 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2021), Ryman Healthcare's Scope 1 emissions remained relatively stable, indicating that Ryman Healthcare's emissions have plateaued with no significant change in its operational footprint.a
In 2024, Ryman Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 8,234 tCO₂e using the market-based method and 9,623 tCO₂e using the location-based method.a
Compared to the previous year (2021), Ryman Healthcare's Scope 2 emissions (Location-Based) rose by 20.27% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2024, Ryman Healthcare reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Ryman Healthcare reported 4,123 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Ryman Healthcare includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2021, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Ryman Healthcare reported total Scope 3 emissions of 4,123 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2021), Ryman Healthcare's Scope 3 emissions increased by 14.53%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, Ryman Healthcare reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to Ryman Healthcare's Scope 3 emissions were:a
In 2024, Ryman Healthcare reported Scope 1 greenhouse gas (GHG) emissions of 4,318 tCO₂e and total revenues of USD 389 millions. This translates into an emissions intensity of 11.1 tCO₂e per millions USD.a
In 2024, Ryman Healthcare reported a Scope 1 emissions intensity of 11.1 tCO₂e per millions USD. Compared to the peer group median of 6.04, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Ryman Healthcare ranked 17 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Ryman Healthcare is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, Ryman Healthcare reported a total carbon footprint of 18,064 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 13.48% increase compared to 2021, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Ryman Healthcare's total carbon footprint was Scope 2 emissions, accounting for 53.27% of the company's total carbon footprint, followed by Scope 1 emissions at 23.9%.a